Active Investments
|
Alvine Treatment of autoimmune/GI diseases with focus on celiac sprue. |
|
Anthera Pharmaceuticals Development of novel therapeutics for cardiovascular and inflammatory diseases. |
|
Ascenta Therapeutics Anti-cancer agents. |
|
Biovail Specialty pharmaceutical company focusing on CNS disorders. Acquirer of Prestwick. |
|
Catalyst Biosciences Protein therapeutics for the treatment of hemophilia, non-hemophilic bleeding, inflammation and autoimmune diseases. |
|
Cebix Developing chronic replacement therapy for the treatment of type 1 diabetic neuropathy. |
|
Durata Therapeutics A biopharmaceutical company focused on antibiotics. |
|
Hyperion Therapeutics A biopharmaceutical company specializing in gastrointestinal and hepatology therapies. |
|
InteKrin Therapeutics Therapeutics for diabetes, obesity, and metabolic disorders. |
|
Intellikine Kinases for treatment of cancer and inflammation. |
|
KaloBios Developer of antibody-based pharmaceutical products. |
|
Marinus Pharmaceuticals Drugs to treat serious neurological disorders. |
|
Movetis A biopharmaceutical company specializing in gastrointestinal (GI) disorders. |
|
NextWave Pharmaceuticals Therapeutic products for pediatric diseases. |
|
Ocera Drugs for the treatment of gastrointestinal and liver diseases. |
|
Orexigen Therapeutics for the treatment of obesity. (NASDAQ: OREX) |
|
Phenomix Forward genetic analysis and drug development. |
|
PregLem A biopharmaceutical company focused on reproductive medicine. |
|
Sorbent Therapeutics Therapies for patients requiring Sodium removal. |
|
Transcept Therapeutics to treat different cancer types. Acquirer of Novacea. |
|
Trius Therapeutics Antibacterial drug developer. |
|
Vicept Therapeutics Dermatologic therapeutic products. |